Bacuri Nut

Bacuri nut (Platonia insignis) contains garcinielliptone FC and morelloflavone, which demonstrate potent antioxidant activity through DPPH radical scavenging (EC50 8.0-10.5 µg/mL) and lipid peroxidation prevention. The seed's high tripalmitin content (50-55%) enhances skin permeability while palmitoleic acid provides emollient properties.

Origin & History

Bacuri Nut (Platonia insignis) is the seed of a tree native to the Amazon rainforest, particularly Brazil and Guyana, thriving in tropical climates. Its unique fatty acid profile, rich in tripalmitin and palmitoleic acid, makes it a potent ingredient for skin regeneration and anti-inflammatory support in functional nutrition.

Historical & Cultural Context

In Amazonian cultures, Bacuri (Platonia insignis) has been treasured for centuries as a botanical healer. Its seeds and therapeutic oil are integral to traditional skincare routines and sacred rituals, symbolizing nourishment, resilience, and ancestral wisdom passed down through generations for skin rejuvenation.

Health Benefits

- Exhibits potent anti-inflammatory properties, primarily attributed to tripalmitin and palmitoleic acid, which reduce cellular inflammation.
- Supports skin regeneration and repair by promoting epithelial cell turnover and barrier function.
- Demonstrates antimicrobial activity, aiding in the prevention and treatment of skin infections caused by bacteria and fungi.
- Promotes wound healing and soothes skin irritation, beneficial for conditions like eczema and acne scars.
- Acts as a natural emollient, deeply moisturizing and nourishing the skin barrier with essential fatty acids.

How It Works

Morelloflavone provides antioxidant activity via DPPH and ABTS radical scavenging pathways, while garcinielliptone FC prevents lipid peroxidation and scavenges nitric oxide and hydroxyl radicals. Hexane seed extracts increase macrophage phagocytic capacity by 49.8% and lysosomal volume by 9.2% at 12.5 µg/mL concentrations. The high tripalmitin content enhances cellular membrane permeability, facilitating active compound delivery.

Scientific Research

Emerging in vitro and preliminary animal studies support Bacuri Nut's anti-inflammatory, antimicrobial, and emollient effects, primarily linked to its tripalmitin and palmitoleic acid content. Research indicates its potential in improving skin texture and accelerating epithelial regeneration, though human clinical trials are still developing.

Clinical Summary

Current evidence is limited to in vitro and preclinical animal studies, with no human clinical trials reported. In Wistar rats receiving 50-250 mg/kg body weight for 14 days, bacuri lyophilized extracts reduced plasma lipid peroxidation and decreased inflammatory cytokines IL-1β, IL-6, and TNF-α in kidney and liver tissues. Acute toxicity studies in rats showed no adverse effects at 2 g/kg oral doses. Human clinical validation remains necessary to confirm therapeutic efficacy and safety profiles.

Nutritional Profile

- Fatty Acids: High in tripalmitin (50–55%), a triglyceride known for skin-conditioning; contains palmitoleic acid (~5%), a monounsaturated fatty acid that mimics human sebum and promotes skin elasticity.
- Antioxidants: Various compounds contributing to protective and anti-aging effects.

Preparation & Dosage

- Traditional Use: Applied topically as a healing balm for insect bites, wounds, and inflammatory skin conditions in Amazonian folk medicine.
- Medicinal Application: Used as a natural remedy to treat eczema, dermatitis, and skin infections.
- Cosmetic Use: Incorporated into creams, butters, and body oils to deeply moisturize and restore damaged skin.
- Application: Typically used topically; recommended daily use in formulations at 5–15% concentration.

Synergy & Pairings

Role: Fat + fiber base
Intention: Skin & Collagen | Immune & Inflammation
Primary Pairings: - Turmeric (Curcuma longa)
- Ginger (Zingiber officinale)
- Chia Seeds (Salvia hispanica)
- Camu Camu (Myrciaria dubia)

Safety & Interactions

Preclinical studies demonstrate low toxicity, with no clinical or behavioral changes observed in Wistar rats at acute oral doses of 2 g/kg. Minimal hemolytic activity and low cellular toxicity have been reported in laboratory testing. The high saturated fatty acid content (64%) may warrant caution in individuals with existing lipid metabolism disorders, though specific contraindications have not been established. No documented drug interactions exist, but comprehensive human safety data remains unavailable due to lack of clinical trials.